Celldex Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Celldex Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Celldex Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 66.3M shares, a 40.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 66.3M +19M +40.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 65.9M +18.7M +39.5% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 55.9M +8.68M +18.4% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 47.3M +168K +0.36% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 47.3M +489K +1.05% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 47.2M +490K +1.05% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 47.2M +470K +1.01% Dec 31, 2022 10-K 2024-02-26
Q3 2022 47.1M +433K +0.93% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 46.8M +7.15M +18% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 46.8M +7.14M +18% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 46.7M +7.13M +18% Dec 31, 2021 10-K 2023-02-28
Q3 2021 46.7M +7.1M +17.9% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 39.6M +523K +1.34% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 39.6M +21.9M +123% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 39.6M +22.6M +133% Dec 31, 2020 10-K 2022-02-28
Q3 2020 39.6M +23.7M +149% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 39.1M +24.3M +164% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 17.7M +4.89M +38% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 17M +5.01M +41.9% Dec 31, 2019 10-K 2021-03-29
Q3 2019 15.9M -153M -90.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 14.8M -142M -90.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 12.8M -131M -91% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 12M +2.72M +29.5% Dec 31, 2018 10-K 2020-03-26
Q3 2018 169M +36.5M +27.6% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 157M +29.2M +22.9% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 143M +19.2M +15.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 9.23M -111M -92.3% Dec 31, 2017 10-K 2019-03-07
Q3 2017 132M +30.9M +30.5% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 127M +28M +28.2% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 124M +25.5M +25.8% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 121M +21.8M +22.1% Dec 31, 2016 10-K 2018-03-07
Q3 2016 101M +2.6M +2.64% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 99.4M +846K +0.86% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 98.7M +238K +0.24% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 98.7M +9.09M +10.1% Dec 31, 2015 10-K 2017-03-14
Q3 2015 98.6M +9.21M +10.3% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 98.5M +9.15M +10.2% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 98.5M +9.12M +10.2% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 89.6M +346K +0.39% Dec 31, 2014 10-K/A 2016-02-25
Q3 2014 89.4M +8.33M +10.3% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 89.4M +8.42M +10.4% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 89.4M +8.49M +10.5% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 89.2M +24.9M +38.7% Dec 31, 2013 10-K 2015-02-24
Q3 2013 81.1M +20.3M +33.4% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 81M +22.2M +37.8% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 80.9M +22.1M +37.7% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 64.4M +20.1M +45.6% Dec 31, 2012 10-K 2014-03-03
Q3 2012 60.8M +16.7M +37.7% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 58.8M +14.6M +33.1% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 58.7M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 44.2M +12.2M +37.9% Dec 31, 2011 10-K 2013-03-08
Q3 2011 44.1M Sep 30, 2011 10-Q 2011-11-03
Q2 2011 44.1M Jun 30, 2011 10-Q 2011-08-04
Q4 2010 32.1M Dec 31, 2010 10-K 2012-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.